117 related articles for article (PubMed ID: 35358902)
21. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.
Fainardi E; Rizzo R; Melchiorri L; Vaghi L; Castellazzi M; Marzola A; Govoni V; Paolino E; Tola MR; Granieri E; Baricordi OR
J Neuroimmunol; 2003 Sep; 142(1-2):149-58. PubMed ID: 14512174
[TBL] [Abstract][Full Text] [Related]
22. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
[TBL] [Abstract][Full Text] [Related]
23. Cytokine network imbalance in children with B-cell acute lymphoblastic leukemia at diagnosis.
Dai Q; Zhang G; Wang Y; Ye L; Shi R; Peng L; Guo S; He J; Yang H; Zhang Y; Jiang Y
Cytokine; 2023 Sep; 169():156267. PubMed ID: 37320964
[TBL] [Abstract][Full Text] [Related]
24. HLA-G expression in acute lymphoblastic leukemia: a significant prognostic tumor biomarker.
Alkhouly N; Shehata I; Ahmed MB; Shehata H; Hassan S; Ibrahim T
Med Oncol; 2013 Mar; 30(1):460. PubMed ID: 23335072
[TBL] [Abstract][Full Text] [Related]
25. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM).
Michallet M; Tanguy ML; Socié G; Thiébaut A; Belhabri A; Milpied N; Reiffers J; Kuentz M; Cahn JY; Blaise D; Demeocq F; Jouet JP; Michallet AS; Ifrah N; Vilmer E; Molina L; Michel G; Lioure B; Cavazzana-Calvo M; Pico JL; Sadoun A; Guyotat D; Attal M; Curé H; Bordigoni P; Sutton L; Buzyn-Veil A; Tilly M; Keoirruer N; Feguex N
Br J Haematol; 2000 Feb; 108(2):400-7. PubMed ID: 10691873
[TBL] [Abstract][Full Text] [Related]
26. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
[TBL] [Abstract][Full Text] [Related]
27. Anti-Relapse effects of donor natural killer cells and IL-2 gene modification on allogeneic hematopoietic stem cell transplantation in acute leukemia.
Xue Z; Gao Y; Wu X
Cancer Biomark; 2020; 29(2):207-219. PubMed ID: 32568180
[TBL] [Abstract][Full Text] [Related]
28. Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival.
Kordelas L; Schwich E; Lindemann M; Heinemann FM; Buttkereit U; Horn PA; Beelen DW; Rebmann V
Front Immunol; 2019; 10():3027. PubMed ID: 31998310
[TBL] [Abstract][Full Text] [Related]
29. Effects of second transplantation with T-cell-replete haploidentical graft using low-dose anti-thymocyte globulin on long-term overall survival in pediatric patients with relapse of leukemia after first allogeneic transplantation.
Kobayashi S; Sano H; Mochizuki K; Ohara Y; Takahashi N; Kudo S; Ikeda K; Ohto H; Kikuta A
Int J Hematol; 2022 Mar; 115(3):414-423. PubMed ID: 34822127
[TBL] [Abstract][Full Text] [Related]
30. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
[TBL] [Abstract][Full Text] [Related]
31. Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.
Pawson R; Potter MN; Theocharous P; Lawler M; Garg M; Yin JA; Rezvani K; Craddock C; Rassam S; Prentice HG
Br J Haematol; 2001 Dec; 115(3):622-9. PubMed ID: 11736947
[TBL] [Abstract][Full Text] [Related]
32. Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages.
Gros F; Sebti Y; de Guibert S; Branger B; Bernard M; Fauchet R; Amiot L
Neoplasia; 2006 Mar; 8(3):223-30. PubMed ID: 16611416
[TBL] [Abstract][Full Text] [Related]
33. New markers for predictions of acute and chronic rejection and graft outcomes in kidney transplant recipients; HLA-G gene 3'UTR 14 bp polymorphism and sHLA-G.
Darbas S; Yilmaz VT; Kocak H; Kisaoglu A; Demiryilmaz I; Aydinli B; Arslan HS; Ucar F
Gene; 2021 Jul; 790():145712. PubMed ID: 33984446
[TBL] [Abstract][Full Text] [Related]
34. [Changes of Th1/Th2/Th17 in patients received non-myeloablative haploidentical hematopoietic stem cell transplantation detected by flow cytometric bead array].
Zhao YY; Kang Y; Sun QY; Dong Z; Liu TQ; Liu GX; Guo M; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):431-5. PubMed ID: 23628048
[TBL] [Abstract][Full Text] [Related]
35. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
36. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era.
Xue YJ; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1611-1620. PubMed ID: 30537550
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies.
Schwenk L; Wittig S; Gruhn B
J Cancer Res Clin Oncol; 2022 Apr; 148(4):985-991. PubMed ID: 34152493
[TBL] [Abstract][Full Text] [Related]
39. Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
Chevallier P; Labopin M; Socie G; Rubio MT; Blaise D; Vigouroux S; Huynh A; Michallet M; Bay JO; Maury S; Yakoub-Agha I; Fegueux N; Deconinck E; Contentin N; Maillard N; Bulabois CE; Francois S; Oumedaly R; Raus N; Mohty M
Eur J Haematol; 2015 May; 94(5):449-55. PubMed ID: 25238651
[TBL] [Abstract][Full Text] [Related]
40. The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors.
Capittini C; Bergamaschi P; Sachetto S; Truglio M; Viola M; Marchesi A; Genovese V; Romano B; Guarene M; Poma R; Martinetti M; Tinelli C; Salvaneschi L
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s361-6. PubMed ID: 23399358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]